JP2007514754A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007514754A5 JP2007514754A5 JP2006545478A JP2006545478A JP2007514754A5 JP 2007514754 A5 JP2007514754 A5 JP 2007514754A5 JP 2006545478 A JP2006545478 A JP 2006545478A JP 2006545478 A JP2006545478 A JP 2006545478A JP 2007514754 A5 JP2007514754 A5 JP 2007514754A5
- Authority
- JP
- Japan
- Prior art keywords
- gallium
- composition
- effective amount
- complex
- preventing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- GYHNNYVSQQEPJS-UHFFFAOYSA-N Gallium Chemical compound [Ga] GYHNNYVSQQEPJS-UHFFFAOYSA-N 0.000 claims 23
- 229910052733 gallium Inorganic materials 0.000 claims 23
- 239000000203 mixture Substances 0.000 claims 19
- 238000002560 therapeutic procedure Methods 0.000 claims 5
- VEYIMQVTPXPUHA-UHFFFAOYSA-N 3-hydroxypyran-4-one Chemical compound OC1=COC=CC1=O VEYIMQVTPXPUHA-UHFFFAOYSA-N 0.000 claims 4
- 206010003246 arthritis Diseases 0.000 claims 4
- 230000002757 inflammatory effect Effects 0.000 claims 3
- 239000004721 Polyphenylene oxide Substances 0.000 claims 2
- 208000025747 Rheumatic disease Diseases 0.000 claims 2
- 201000009594 Systemic Scleroderma Diseases 0.000 claims 2
- 206010042953 Systemic sclerosis Diseases 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- AJNVQOSZGJRYEI-UHFFFAOYSA-N digallium;oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Ga+3].[Ga+3] AJNVQOSZGJRYEI-UHFFFAOYSA-N 0.000 claims 2
- 150000002258 gallium Chemical class 0.000 claims 2
- CHPZKNULDCNCBW-UHFFFAOYSA-N gallium nitrate Chemical compound [Ga+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O CHPZKNULDCNCBW-UHFFFAOYSA-N 0.000 claims 2
- 229910001195 gallium oxide Inorganic materials 0.000 claims 2
- 230000007935 neutral effect Effects 0.000 claims 2
- 229920000570 polyether Polymers 0.000 claims 2
- YEEGWNXDUZONAA-UHFFFAOYSA-K 5-hydroxy-2,8,9-trioxa-1-gallabicyclo[3.3.2]decane-3,7,10-trione Chemical compound [Ga+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O YEEGWNXDUZONAA-UHFFFAOYSA-K 0.000 claims 1
- 206010002556 Ankylosing Spondylitis Diseases 0.000 claims 1
- 208000006386 Bone Resorption Diseases 0.000 claims 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 claims 1
- 206010007710 Cartilage injury Diseases 0.000 claims 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 claims 1
- KRHYYFGTRYWZRS-UHFFFAOYSA-M Fluoride anion Chemical compound [F-] KRHYYFGTRYWZRS-UHFFFAOYSA-M 0.000 claims 1
- BDAGIHXWWSANSR-UHFFFAOYSA-M Formate Chemical compound [O-]C=O BDAGIHXWWSANSR-UHFFFAOYSA-M 0.000 claims 1
- 208000007465 Giant cell arteritis Diseases 0.000 claims 1
- 206010072579 Granulomatosis with polyangiitis Diseases 0.000 claims 1
- 208000003456 Juvenile Arthritis Diseases 0.000 claims 1
- 206010059176 Juvenile idiopathic arthritis Diseases 0.000 claims 1
- 208000003250 Mixed connective tissue disease Diseases 0.000 claims 1
- 241001111421 Pannus Species 0.000 claims 1
- 201000001263 Psoriatic Arthritis Diseases 0.000 claims 1
- 208000036824 Psoriatic arthropathy Diseases 0.000 claims 1
- 208000033464 Reiter syndrome Diseases 0.000 claims 1
- 206010041660 Splenomegaly Diseases 0.000 claims 1
- 239000007983 Tris buffer Substances 0.000 claims 1
- 206010047115 Vasculitis Diseases 0.000 claims 1
- 230000015572 biosynthetic process Effects 0.000 claims 1
- 230000024279 bone resorption Effects 0.000 claims 1
- 208000019069 chronic childhood arthritis Diseases 0.000 claims 1
- 201000001981 dermatomyositis Diseases 0.000 claims 1
- FYWVTSQYJIPZLW-UHFFFAOYSA-K diacetyloxygallanyl acetate Chemical group [Ga+3].CC([O-])=O.CC([O-])=O.CC([O-])=O FYWVTSQYJIPZLW-UHFFFAOYSA-K 0.000 claims 1
- 229940044658 gallium nitrate Drugs 0.000 claims 1
- 229910000154 gallium phosphate Inorganic materials 0.000 claims 1
- UPWPDUACHOATKO-UHFFFAOYSA-K gallium trichloride Chemical compound Cl[Ga](Cl)Cl UPWPDUACHOATKO-UHFFFAOYSA-K 0.000 claims 1
- LWFNJDOYCSNXDO-UHFFFAOYSA-K gallium;phosphate Chemical compound [Ga+3].[O-]P([O-])([O-])=O LWFNJDOYCSNXDO-UHFFFAOYSA-K 0.000 claims 1
- 208000028774 intestinal disease Diseases 0.000 claims 1
- 201000002215 juvenile rheumatoid arthritis Diseases 0.000 claims 1
- 208000005987 polymyositis Diseases 0.000 claims 1
- 230000035755 proliferation Effects 0.000 claims 1
- 208000002574 reactive arthritis Diseases 0.000 claims 1
- 206010039073 rheumatoid arthritis Diseases 0.000 claims 1
- 210000002966 serum Anatomy 0.000 claims 1
- 201000000596 systemic lupus erythematosus Diseases 0.000 claims 1
- 229940095064 tartrate Drugs 0.000 claims 1
- 206010043207 temporal arteritis Diseases 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US53035303P | 2003-12-17 | 2003-12-17 | |
| PCT/US2004/042453 WO2005058331A1 (en) | 2003-12-17 | 2004-12-17 | Use of gallium to treat inflammatory arthritis |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007514754A JP2007514754A (ja) | 2007-06-07 |
| JP2007514754A5 true JP2007514754A5 (enExample) | 2007-09-06 |
Family
ID=34700126
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006545478A Pending JP2007514754A (ja) | 2003-12-17 | 2004-12-17 | 炎症性関節炎を処置するためのガリウムの使用 |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US20050220895A1 (enExample) |
| EP (1) | EP1694341A1 (enExample) |
| JP (1) | JP2007514754A (enExample) |
| CN (1) | CN1917889A (enExample) |
| AU (1) | AU2004299126A1 (enExample) |
| CA (1) | CA2550119A1 (enExample) |
| MX (1) | MXPA06006801A (enExample) |
| WO (1) | WO2005058331A1 (enExample) |
| ZA (1) | ZA200605583B (enExample) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2003279067A1 (en) * | 2002-09-23 | 2004-04-08 | Genta Inc. | Tri(alkylcarboxylato) gallium (iii) products and pharmaceutical compositions containing them |
| WO2007100382A2 (en) * | 2005-10-27 | 2007-09-07 | Bernstein Lawrence R | Orally administrable gallium compositions and method of use |
| US20110038809A1 (en) * | 2005-11-01 | 2011-02-17 | Perl Daniel P | Growth control of oral and superficial microorganisms using gallium compounds |
| CN101300033A (zh) * | 2005-11-07 | 2008-11-05 | 泰坦医药品公司 | 用镓对不良肝脏病症的治疗和预防 |
| US7993675B2 (en) | 2006-05-10 | 2011-08-09 | Medtronic Xomed, Inc. | Solvating system and sealant for medical use in the sinuses and nasal passages |
| US20070264296A1 (en) * | 2006-05-10 | 2007-11-15 | Myntti Matthew F | Biofilm extracellular polysachharide solvating system |
| US7976873B2 (en) | 2006-05-10 | 2011-07-12 | Medtronic Xomed, Inc. | Extracellular polysaccharide solvating system for treatment of bacterial ear conditions |
| US7959943B2 (en) | 2006-05-10 | 2011-06-14 | Medtronics Xomed, Inc. | Solvating system and sealant for medical use in the middle or inner ear |
| EP2099464B1 (en) | 2006-11-09 | 2016-05-25 | BERNSTEIN, Lawrence Richard | Local administration of gallium compositions to treat pain |
| US8088095B2 (en) | 2007-02-08 | 2012-01-03 | Medtronic Xomed, Inc. | Polymeric sealant for medical use |
| EP2526773A1 (en) * | 2007-04-02 | 2012-11-28 | Mount Sinai School Of Medicine | Methods for preventing or treating infectious diseases using gallium compounds |
| EP2262509A4 (en) * | 2008-03-07 | 2012-02-22 | Lawrence Bernstein | GALLIUM COMPOUNDS AND METHOD OF USE FOR THE TREATMENT OF INFLAMMATORY ENDURANCE |
| CA2727432C (en) | 2008-06-12 | 2016-10-11 | Medtronic Xomed, Inc. | Method for treating chronic wounds with an extracellular polymeric substance solvating system |
| US20100086576A1 (en) * | 2008-10-06 | 2010-04-08 | Myntti Matthew F | Antimicrobial composition and methods of making and using same |
| EP2413698A4 (en) * | 2009-03-30 | 2013-07-10 | Niiki Pharma Inc | PROCESS FOR TREATING OSTEOPOROSIS |
| EP2706845B1 (en) | 2011-05-10 | 2021-06-23 | Next Science IP Holdings Pty Ltd | Antimicrobial solid and methods of making and using same |
| US10889556B2 (en) | 2016-03-08 | 2021-01-12 | The Regents Of The University Of California | Compositions and methods for inhibiting influenza RNA polymerase PA endonuclease |
| WO2017156194A1 (en) * | 2016-03-08 | 2017-09-14 | The Regents Of The University Of California | Compositions and methods for inhibiting influenza rna polymerase pa endonuclease |
| CN110381945A (zh) * | 2017-02-10 | 2019-10-25 | 阿尔图姆制药股份有限公司 | 口服给予的镓（iii）配合物的组合物 |
| US10537661B2 (en) | 2017-03-28 | 2020-01-21 | DePuy Synthes Products, Inc. | Orthopedic implant having a crystalline calcium phosphate coating and methods for making the same |
| US10537658B2 (en) | 2017-03-28 | 2020-01-21 | DePuy Synthes Products, Inc. | Orthopedic implant having a crystalline gallium-containing hydroxyapatite coating and methods for making the same |
| WO2019226519A1 (en) | 2018-05-24 | 2019-11-28 | Celanese EVA Performance Polymers Corporation | Implantable device for sustained release of a macromolecular drug compound |
| EP3801462A4 (en) | 2018-05-24 | 2022-03-16 | Celanese EVA Performance Polymers LLC | Implantable device for sustained release of a macromolecular drug compound |
| WO2019222856A1 (en) | 2018-05-24 | 2019-11-28 | Nureva Inc. | Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones |
| JP2024515220A (ja) | 2021-04-26 | 2024-04-05 | セラニーズ・イーブイエイ・パフォーマンス・ポリマーズ・エルエルシー | 高分子薬剤化合物の持続放出用の埋め込み型デバイス |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3519361A1 (de) * | 1985-05-30 | 1986-12-04 | Boehringer Ingelheim International GmbH, 6507 Ingelheim | (gamma)-ifn als wirkstoff zur hemmung (verhinderung) von abbauprozessen im knochen |
| EP0330799A1 (en) * | 1988-03-03 | 1989-09-06 | Schering Aktiengesellschaft | A method for the treatment of arthritis and inflammatory joint diseases |
| US5258376A (en) * | 1989-11-22 | 1993-11-02 | Bernstein Lawrence R | Pharmaceutical compositions of gallium complexes of 3-hydroxy-4-pyrones |
| US6004951A (en) * | 1989-11-22 | 1999-12-21 | Bernstein; Lawrence Richard | Administration of gallium complexes of 3-hydroxy-4-pyrones to provide physiologically active gallium levels in a mammalian individual |
| US5175006A (en) * | 1990-09-21 | 1992-12-29 | The Ohio State University | Method of treating arthritis using gallium compounds |
| EP0599881B1 (en) * | 1991-07-25 | 1998-05-13 | Philippe Collery | Gallium (iii) complexes, process for their obtention and pharmaceutical compositions containing them |
| ES2151486T3 (es) * | 1991-11-12 | 2001-01-01 | Lawrence Richard Bernstein | Composiciones farmaceuticas que contienen complejos de 3-hidroxi-4-pironas. |
| US5902825A (en) * | 1997-01-07 | 1999-05-11 | Mitreoak, Ltd. | Composition and method for the palliation of pain associated with diseases of the bone and bone joints |
| US6303804B1 (en) * | 1999-05-07 | 2001-10-16 | Raytheon Company | Environmentally benign bismuth-containing spin-on precursor materials |
| US6054600A (en) * | 1999-05-07 | 2000-04-25 | Raytheon Company | Non-toxic solvent soluble group IV and V metal acid salt complexes using polyether acid anhydrides |
| JP2003510362A (ja) * | 1999-10-04 | 2003-03-18 | ローレンス・アール・バーンスタイン | 細胞内原核生物、ｄｎａウイルス及びレトロウイルスによる感染を治療するための、３−ヒドロキシ−４−ピロンのガリウム錯体 |
| US20020068761A1 (en) * | 1999-10-04 | 2002-06-06 | Bernstein Lawrence R. | Gallium complexes of 3-hydroxy-4-pyrones to treat mycobacterial infections |
-
2004
- 2004-12-17 ZA ZA200605583A patent/ZA200605583B/xx unknown
- 2004-12-17 CA CA002550119A patent/CA2550119A1/en not_active Abandoned
- 2004-12-17 CN CNA2004800417601A patent/CN1917889A/zh active Pending
- 2004-12-17 US US11/015,172 patent/US20050220895A1/en not_active Abandoned
- 2004-12-17 EP EP04814610A patent/EP1694341A1/en not_active Withdrawn
- 2004-12-17 WO PCT/US2004/042453 patent/WO2005058331A1/en not_active Ceased
- 2004-12-17 AU AU2004299126A patent/AU2004299126A1/en not_active Abandoned
- 2004-12-17 MX MXPA06006801A patent/MXPA06006801A/es not_active Application Discontinuation
- 2004-12-17 JP JP2006545478A patent/JP2007514754A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2007514754A5 (enExample) | ||
| ES2310417T3 (es) | Procedimiento para tratar la insuficiencia renal. | |
| JP2005525345A5 (enExample) | ||
| MY130755A (en) | Colchinol derivatives as vascular damaging agents | |
| DE60220403D1 (de) | Zusammensetzung zur unterdrückung von magensäure | |
| RU2000113729A (ru) | Гетероциклические соединения для ингибирования секреции желудочной кислоты, способы их получения и их фармацевтические компоозиции | |
| JP2005508981A5 (enExample) | ||
| JP2006516648A5 (enExample) | ||
| JP2006511457A5 (enExample) | ||
| JP2005506294A5 (enExample) | ||
| JP2022188083A5 (enExample) | ||
| JP2002527474A5 (ja) | 躁病および双極性障害の治療のための医薬 | |
| ES2236300T3 (es) | Composiciones de hierro. | |
| RU2003129527A (ru) | Способ и дозированная форма для опухолей путем введения тегафура, урацила, фолиновой кислоты, паклитаксела и карбоплатины | |
| AP2004003160A0 (en) | Tolterodine salts | |
| JP2006522824A5 (enExample) | ||
| WO2002080942A1 (en) | Pharmaceutical composition comprising copper, salicyclic acid, vitamin c and zinc for use in treatment of different diseases such as bacterial or viral infection | |
| JP2006516643A5 (enExample) | ||
| HUP0104374A2 (hu) | Növekedési hormont felszabadító vegyületek és antagonistáik tumorok kezeléseire való alkalmazásra | |
| KR100812693B1 (ko) | 항종양 효과 증강제 및 항종양제 | |
| KR102319863B1 (ko) | 2아세트산 알칼리 금속염을 포함하는 고형 투석용 a제, 및 그것을 사용한 2제형의 저아세트산 투석용제 | |
| CA2386423C (en) | Pharmaceutical compositions containing copper, salicylic acid and vitamines c | |
| JP2004521126A5 (enExample) | ||
| JP2003510255A5 (enExample) | ||
| JP2003519683A5 (enExample) |